Key facts
- It has raised $3.3M; the latest was Early Stage VC ($2.5M) in Apr 2026.
- Notable investors include Tiny Supercomputer Investment Company, Scrum Ventures, Oxford Saïd Business School, Supermoon Capital, The Yope Foundation.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Lume Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Lume Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lume Health
Developer of a biosensor and AI-driven monitoring device designed for health and wellness management. The company's device utilizes a continuous hormone monitor to measure hourly cortisol levels through sweat and provides personalized, AI-driven insights and actionable daily habits to help users understand their bodies and naturally improve their energy and sleep, enabling individuals to achieve better physiological balance and overall well-being.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 9
- Website
- lumehealth.io/
- Ownership
- Privately Held (backing)
Lume Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lume Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lume Health in its N-PORT filings yet. We sweep new filings monthly.